Portal


Raghu Das
Raghu Das
IDTechEx
+44 (0)1223 810275
Email Engagement Manager

Upcoming webinars

Industry news as covered by IDTechEx journals.

CRISPR Modified Stem Cell Therapy for Type 1 Diabetes

13 May 2022 | Canada
Researchers have received $1 million from Canada's Stem Cell Network to conduct research and a clinical trial for one of the world's first genetically engineered cell replacement therapies for type 1 diabetes. The researchers say the study is an important step toward developing a potential functional cure for type 1 diabetes.
Login or Register You are not logged in. Please login or register with idtechex.com for more details about premium content from IDTechEx.